Vimarsana
Biggest News Aggregation in the World

Page 20 - Benzinga Pro News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Benzinga Pro. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Benzinga Pro Today - Breaking & Trending Today

Check Out What Whales Are Doing With Morgan Stanley - Morgan Stanley (NYSE:MS) - Vimarsana News

Check Out What Whales Are Doing With Morgan Stanley - Morgan Stanley (NYSE:MS)

Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug - Vimarsana News

Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug

Tuesday, the FDA approved Amgen Inc (NASDAQ:AMGN) Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to AstraZeneca Plc’s (NASDAQ:AZN) Soliris (eculizumab) to treat certain rare diseases. Bkemv is approved for the following treatment indications, which are also currently approved for Soliris: The treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH) to reduce hemolysis. The treatment of patients with atypical hemolytic uremic syndrome (aHUS) to inhibit complement-medi

Source: yahoo.com
Why Cue Health Shares Are Getting Hammered - Cue Health (NASDAQ:HLTH) - Vimarsana News

Why Cue Health Shares Are Getting Hammered - Cue Health (NASDAQ:HLTH)

Cue Health shares are trading lower by 27.5% during Wednesday's session. The company announced that it filed voluntary petitions under Chapter 7 of the U.S. Bankruptcy Code.

What's Going On With UiPath Stock Ahead Of Earnings? - UiPath (NYSE:PATH) - Vimarsana News

What's Going On With UiPath Stock Ahead Of Earnings? - UiPath (NYSE:PATH)

UiPath shares are trading lower on heavy volume Wednesday ahead of the company's first-quarter earnings report. Here's a look at what's going on.

(SINT) - Analyzing SINTX Techs's Short Interest - SINTX Techs (NASDAQ:SINT) - Vimarsana News

(SINT) - Analyzing SINTX Techs's Short Interest - SINTX Techs (NASDAQ:SINT)